GovChime
Notice ID: b96d72aaf5ff79f5bd4fa20e02724b17Combined Synopsis/Solicitation

65--30 assay kits needed to test for BoNT, A/E (SNAP25 cleavage) and 20 assay kits that test for BoNT/B/D/F/and G (synaptobrevin cleavage). These BoTest supplies are for testing potential peptide inhibitors of Botulinum Neurotoxin Type A.

Archived on June 7, 2014. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
7:00 AM UTC+02:00
Posted
April 8, 2014
Notice type
Combined Synopsis/Solicitation
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing

Notice details

Place of performance
US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD 21702-5014 US
PSC
65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Last updated
Dec 3, 2025

Identifiers

Solicitation number
W81XWH14T0160
Notice ID
b96d72aaf5ff79f5bd4fa20e02724b17

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. Minimum Essential Characteristics (MECs) 1.-Required for the routine detection of botulinum neurotoxin (BoNT) serotypes A B, C, D, E, F and G. The assay must have the ability to measure accurately BoNT's proteolytic cleavage of natural BoNT substrates - SNAP25 or VAMP2 - in a sensitive, FRET-based, mix and read format and using most standard fluorescent plate readers. 2.-The FRET-based nature of the assays allows for real-time detection of BoNT proteolytic activity enabling the determination of kinetic constants and the determination of enzymatic activity. 3.-Assay must have picomolar to fentomolar sensitivity. 4.-Assay must contain a reporter that consists of residues 141-206 (66-MER) of SNAP-25, the naturally occurring substrate of BoNT/A and E. The substrate must be sandwiched between two fluorescent proteins, a cyan fluorescent protein (CFP) derivative, and a yellow fluorescent protein (YFP) derivative. 5.-The CFP and YFP moieties on the 66-MER (SNAP-25 derivative) must form a donor-acceptor F rster Resonance Energy Transfer (FRET) pair. 6.-Reporter must have an excitation wavelength of 435 nm and an emission wavelength of 527 nm for SNAP-25 cleavage detection. 7.-Assay must contain a reporter that consists of residues 33-94 (62-MER) of synaptobrevin, the naturally occurring substrate of BoNT/B/D/F/and G. The substrate must be sandwiched between two fluorescent proteins, a cyan fluorescent protein (CFP) derivative, and a yellow fluorescent protein (YFP) derivative. 8.-The CFP and YFP moieties on the 62-MER (synaptobrevin derivative) must form a donor-acceptor F rster Resonance Energy Transfer (FRET) pair. 9.-Reporter must have an excitation wavelength of 435 nm and an emission wavelength of 527 nm for synaptobrevin cleavage detection. 10.-Assay must include a viable reaction (HEPES based) buffer system that is favorable for both Light chain and holotoxin studies. 11.-Must include 30 assay kits that test for BoNT, A/E (SNAP25 cleavage) and 20 assay kits that test for BoNT/B/D/F/and G (synaptobrevin cleavage). 12.-Must include shipping and handling costs in order. If questions, please contact me: Hugo Robinson; hugo.m.robinson.civ@mail.mil; 301-619-7811. Thank-you.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Hugo Robinson, 301-619-7811 US Army Medical Research Acquisition Activity

Documents

No documents available.

Lifecycle

Solicitation:W81XWH14T0160
  1. Combined Synopsis
  1. Combined SynopsisCurrentApr 8, 2014

    65--30 assay kits needed to test for BoNT, A/E (SNAP25 cleavage) and 20 assay kits that test for BoNT/B/D/F/and G (synaptobrevin cleavage). These BoTest supplies are for testing potential peptide inhibitors of Botulinum Neurotoxin Type A.

    Notice b96d72aaf5ff79f5bd4fa20e02724b17 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

W81XWH14T0160

Archive Date

Jun 7, 2014